Cells expressing the cytokine’s receptors are not targeted for killing; the secreted cytokine activates/augments immune cells. Killing is directed at EBV peptide–HLA–positive tumor cells by the engineered TCR-T cells via perforin/granzyme (and Fas/FasL) cytolysis.